| Reference |
|---|
Lin C, Traets J, Vredevoogd D, Visser N, Peeper D. TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. EMBO J. 2023;42:e111614 pubmed publisher |
Ib xe1 xf1 ez Molero S, van Vliet A, Poźniak J, Hummelink K, Terry A, Monkhorst K, et al. SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response. Oncoimmunology. 2022;11:2139074 pubmed publisher |
Ishii Y, Kolluri K, Pennycuick A, Zhang X, Nigro E, Alrifai D, et al. BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. J Biol Chem. 2021;297:101223 pubmed publisher |
Locquet M, Ichim G, Bisaccia J, Dutour A, Lebecque S, Castets M, et al. Caspase-8 deficiency induces a switch from TLR3 induced apoptosis to lysosomal cell death in neuroblastoma. Sci Rep. 2021;11:10609 pubmed publisher |
Crosley P, Färkkilä A, Jenner A, Burlot C, Cardinal O, Potts K, et al. Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro. Int J Mol Sci. 2021;22: pubmed publisher |
Miles M, Hawkins C. In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations. Cell Death Dis. 2020;11:680 pubmed publisher |
Jiang Y, Wen T, Yan R, Kim S, Stowell S, Wang W, et al. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization. FASEB J. 2020;34:11786-11801 pubmed publisher |
Braunstein I, Engelman R, Yitzhaki O, Ziv T, Galardon E, Benhar M. Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation. J Biol Chem. 2020;295:3590-3600 pubmed publisher |
Uddin M, Pimentel J, Chatterjee M, Allen J, Zhuang Z, Wu G. Targeting PP2A inhibits the growth of triple-negative breast cancer cells. Cell Cycle. 2020;19:592-600 pubmed publisher |
Wang M, LAW M, Davis B, Yaaghubi E, Ghilardi A, Ferreira R, et al. Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discov. 2019;5:153 pubmed publisher |
Hope J, Lopez Cavestany M, Wang W, Reinhart King C, King M. Activation of Piezo1 sensitizes cells to TRAIL-mediated apoptosis through mitochondrial outer membrane permeability. Cell Death Dis. 2019;10:837 pubmed publisher |
Lee S, Quan K, Byun H, Park I, Kang K, Piao X, et al. Accelerated degradation of cFLIPL and sensitization of the TRAIL DISC-mediated apoptotic cascade by pinoresinol, a lignan isolated from Rubia philippinensis. Sci Rep. 2019;9:13505 pubmed publisher |
Nieddu V, Piredda R, Bexell D, Barton J, Anderson J, Sebire N, et al. Engineered human mesenchymal stem cells for neuroblastoma therapeutics. Oncol Rep. 2019;42:35-42 pubmed publisher |
Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker A, et al. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocr Relat Cancer. 2019;26:551-563 pubmed publisher |
Deveaux W, Hayashi K, Selvarajoo K. Defining rules for cancer cell proliferation in TRAIL stimulation. NPJ Syst Biol Appl. 2019;5:5 pubmed publisher |
Spano C, Grisendi G, Golinelli G, Rossignoli F, Prapa M, Bestagno M, et al. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer. Sci Rep. 2019;9:1788 pubmed publisher |
Zhu Z, Liu J, Yang C, Li M, Wu R, Xiong Z. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells. Cell Death Dis. 2019;10:118 pubmed publisher |
Nalli A, Brown L, Thomas C, Sayers T, Porco J, Henrich C. Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs. Sci Rep. 2018;8:17519 pubmed publisher |
Golinelli G, Grisendi G, Prapa M, Bestagno M, Spano C, Rossignoli F, et al. Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors. Cancer Gene Ther. 2018;: pubmed publisher |
Lincoln F, Imig D, Boccellato C, Juric V, Noonan J, Kontermann R, et al. Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism. Cell Death Dis. 2018;9:1112 pubmed publisher |
Da xdf ler Plenker J, Paschen A, Putschli B, Rattay S, Schmitz S, Goldeck M, et al. Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cells. Int J Cancer. 2019;144:1645-1656 pubmed publisher |
Shiloh R, Gilad Y, Ber Y, Eisenstein M, Aweida D, Bialik S, et al. Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy. Nat Commun. 2018;9:1759 pubmed publisher |
Legler K, Hauser C, Egberts J, Willms A, Heneweer C, Boretius S, et al. The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. Cell Death Dis. 2018;9:445 pubmed publisher |
Yulis M, Quirós M, Hilgarth R, Parkos C, Nusrat A. Intracellular Desmoglein-2 cleavage sensitizes epithelial cells to apoptosis in response to pro-inflammatory cytokines. Cell Death Dis. 2018;9:389 pubmed publisher |
Zhang N, Liu X, Liu L, Deng Z, Zeng Q, Pang W, et al. Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma. Cell Death Dis. 2018;9:230 pubmed publisher |
Delannoy A, Wilhelm E, Eilebrecht S, Alvarado Cuevas E, Benecke A, Bell B. BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis. Cell Death Dis. 2018;9:70 pubmed publisher |
Elia A, Henry Grant R, Adiseshiah C, Marboeuf C, Buckley R, Clemens M, et al. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Cell Death Dis. 2017;8:3204 pubmed publisher |
Miles M, Hawkins C. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 2017;8:e3062 pubmed publisher |
Xu L, Zhang Y, Qu X, Che X, Guo T, Li C, et al. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells. Mol Oncol. 2017;11:1733-1751 pubmed publisher |
Oh Y, Deng L, Deng J, Sun S. The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5. Sci Rep. 2017;7:8027 pubmed publisher |
Brasacchio D, Alsop A, Noori T, Lufti M, Iyer S, Simpson K, et al. Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization. Cell Death Differ. 2017;24:961-970 pubmed publisher |
Carr R, Qiao G, Qin J, Jayaraman S, Prabhakar B, Maker A. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis. Cell Death Discov. 2016;2:16067 pubmed publisher |
Chen L, Xia G, Qiu F, Wu C, Denmon A, Zi X. Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2? and inhibits tumor growth. Sci Rep. 2016;6:32582 pubmed publisher |
Mohammadpour H, Pourfathollah A, Nikougoftar Zarif M, Shahbazfar A. Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model. Sci Rep. 2016;6:28433 pubmed publisher |
Zhou W, Feng X, Han Han -, Guo S, Wang G. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells. Sci Rep. 2016;6:28004 pubmed publisher |
Oh Y, Deng J, Yue P, Sun S. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells. Sci Rep. 2016;6:26803 pubmed publisher |
Choi J, Lim J, Wickramanayake D, Wagley Y, Kim J, Lee H, et al. Characterization of MUDENG, a novel anti-apoptotic protein. Oncogenesis. 2016;5:e221 pubmed publisher |
Fauster A, Rebsamen M, Huber K, Bigenzahn J, Stukalov A, Lardeau C, et al. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis. 2015;6:e1767 pubmed publisher |
Li J, Sharkey C, King M. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death. Sci Rep. 2015;5:9987 pubmed publisher |
Henrich C, Brooks A, Erickson K, Thomas C, Bokesch H, Tewary P, et al. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation. Cell Death Dis. 2015;6:e1666 pubmed publisher |
Grisendi G, Spano C, D Souza N, Rasini V, Veronesi E, Prapa M, et al. Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas. Stem Cells. 2015;33:859-69 pubmed publisher |
Koh D, Han D, Ryu H, Choi W, Jeon B, Kim M, et al. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. Proc Natl Acad Sci U S A. 2014;111:15078-83 pubmed publisher |
Edagawa M, Kawauchi J, Hirata M, Goshima H, Inoue M, Okamoto T, et al. Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through . J Biol Chem. 2014;289:21544-61 pubmed publisher |
Jazirehi A, Kurdistani S, Economou J. Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway. J Immunol. 2014;192:3981-9 pubmed publisher |
Teng Y, Gao M, Wang J, Kong Q, Hua H, Luo T, et al. Inhibition of eIF2? dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells. Cell Death Dis. 2014;5:e1060 pubmed publisher |
Ma H, Rao L, Wang H, Mao Z, Lei R, Yang Z, et al. Transcriptome analysis of glioma cells for the dynamic response to ?-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas. Cell Death Dis. 2013;4:e895 pubmed publisher |
Burckstummer T, Banning C, Hainzl P, Schobesberger R, Kerzendorfer C, Pauler F, et al. A reversible gene trap collection empowers haploid genetics in human cells. Nat Methods. 2013;10:965-71 pubmed publisher |
King H, Cobbold L, Pichon X, Pöyry T, Wilson L, Booden H, et al. Remodelling of a polypyrimidine tract-binding protein complex during apoptosis activates cellular IRESs. Cell Death Differ. 2014;21:161-71 pubmed publisher |
Xu J, Xu Z, Zhou J, Zhuang Z, Wang E, Boerner J, et al. Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem. 2013;288:33263-71 pubmed publisher |
Gupta S, Francis S, Nair M, Mo Y, Aggarwal B. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-C. J Biol Chem. 2013;288:32343-56 pubmed publisher |
Matthews G, Lefebure M, Doyle M, Shortt J, Ellul J, Chesi M, et al. Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma. Cell Death Dis. 2013;4:e798 pubmed publisher |
Turner A, Li L, Pilli T, Qian L, Wiley E, Setty S, et al. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. PLoS ONE. 2013;8:e56817 pubmed publisher |
Reuss D, Mucha J, Hagenlocher C, Ehemann V, Kluwe L, Mautner V, et al. Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS. PLoS ONE. 2013;8:e57152 pubmed publisher |
Hong S, Kim H, Kim J, Ha H, Kim Y, Bae E, et al. Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. J Biol Chem. 2013;288:3560-70 pubmed publisher |
Zhang S, Li G, Zhao Y, Liu G, Wang Y, Ma X, et al. Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells. PLoS ONE. 2012;7:e51461 pubmed publisher |
Lane D, Matte I, Rancourt C, Pich xe9 A. Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. J Ovarian Res. 2012;5:34 pubmed publisher |
Grunert M, Gottschalk K, Kapahnke J, Gündisch S, Kieser A, Jeremias I. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-?B by TRAIL. Cell Death Dis. 2012;3:e414 pubmed publisher |
Le Goff A, Ji Z, Leclercq B, Bourette R, Mougel A, Guerardel C, et al. Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling. J Biol Chem. 2012;287:35382-96 pubmed publisher |
Hsieh Y, Chien K, Lin S, Sabu S, Hsu R, Chi L, et al. Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3. Cell Death Dis. 2012;3:e347 pubmed publisher |
Kong R, Jia G, Cheng Z, Wang Y, Mu M, Wang S, et al. Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. PLoS ONE. 2012;7:e37222 pubmed publisher |
Huang D, Chao Y, Tai M, Yu Y, Lin W. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. J Biomed Sci. 2012;19:35 pubmed publisher |
Agard N, Mahrus S, Trinidad J, Lynn A, Burlingame A, Wells J. Global kinetic analysis of proteolysis via quantitative targeted proteomics. Proc Natl Acad Sci U S A. 2012;109:1913-8 pubmed publisher |
Furusawa Y, Fujiwara Y, Campbell P, Zhao Q, Ogawa R, Hassan M, et al. DNA double-strand breaks induced by cavitational mechanical effects of ultrasound in cancer cell lines. PLoS ONE. 2012;7:e29012 pubmed publisher |
Vindrieux D, R xe9 veiller M, Chantepie J, Yakoub S, Deschildre C, Ruffion A, et al. Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis. Cancer Cell Int. 2011;11:42 pubmed publisher |
Chen Q, Zhang X, Massagué J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 2011;20:538-49 pubmed publisher |
Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, et al. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression. Mol Cancer Ther. 2011;10:1969-81 pubmed publisher |
Xie Z, Quan M, Liu F, Cao J, Zhang J. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. BMC Cancer. 2011;11:322 pubmed publisher |
Maurer G, Brucker D, Bähr O, Harter P, Hattingen E, Walenta S, et al. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer. 2011;11:315 pubmed publisher |
Tang H, Qin Y, Li J, Gong X. The scavenging of superoxide radicals promotes apoptosis induced by a novel cell-permeable fusion protein, sTRAIL:FeSOD, in tumor necrosis factor-related apoptosis-inducing ligand-resistant leukemia cells. BMC Biol. 2011;9:18 pubmed publisher |
Siegelin M, Dohi T, Raskett C, Orlowski G, Powers C, Gilbert C, et al. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest. 2011;121:1349-60 pubmed publisher |
Fu L, Lin Y, Elrod H, Yue P, Oh Y, Li B, et al. c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Mol Cancer. 2010;9:315 pubmed publisher |
Jang J, Jeon Y, Choi Y, Kim C. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression. Mol Cancer. 2010;9:262 pubmed publisher |
Grabarczyk P, Nähse V, Delin M, Przybylski G, Depke M, Hildebrandt P, et al. Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation. PLoS ONE. 2010;5: pubmed publisher |
Goncharenko Khaider N, Lane D, Matte I, Rancourt C, Pich xe9 A. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells. Oncogene. 2010;29:5523-36 pubmed publisher |
Kauh J, Fan S, Xia M, Yue P, Yang L, Khuri F, et al. c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. PLoS ONE. 2010;5:e10376 pubmed publisher |
Xu J, Zhou J, Wei W, Wu G. Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells. PLoS ONE. 2010;5:e10226 pubmed publisher |
Fan S, Li Y, Yue P, Khuri F, Sun S. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation. Neoplasia. 2010;12:346-56 pubmed |
Qiu J, Xiao J, Han C, Li N, Shen X, Jiang H, et al. Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4. J Biol Chem. 2010;285:12241-7 pubmed publisher |
Lane D, Matte I, Rancourt C, Piche A. The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. J Ovarian Res. 2010;3:1 pubmed publisher |
Chen S, Fu L, Raja S, Yue P, Khuri F, Sun S. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis. Mol Cancer. 2010;9:23 pubmed publisher |
Szliszka E, Czuba Z, Bronikowska J, Mertas A, Paradysz A, Krol W. Ethanolic Extract of Propolis Augments TRAIL-Induced Apoptotic Death in Prostate Cancer Cells. Evid Based Complement Alternat Med. 2011;2011:535172 pubmed publisher |
Roth P, Kissel M, Herrmann C, Eisele G, Leban J, Weller M, et al. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo. Clin Cancer Res. 2009;15:6609-18 pubmed publisher |
Elias A, Siegelin M, Steinmüller A, von Deimling A, Lass U, Korn B, et al. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas. Clin Cancer Res. 2009;15:5457-65 pubmed publisher |
Norian L, Kucaba T, Earel J, Knutson T, Vanoosten R, Griffith T. Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors. J Oncol. 2009;2009:408038 pubmed |
Menon L, Kelly K, Yang H, Kim S, Black P, Carroll R. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells. 2009;27:2320-30 pubmed publisher |
Morioka S, Omori E, Kajino T, Kajino Sakamoto R, Matsumoto K, Ninomiya Tsuji J. TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Oncogene. 2009;28:2257-65 pubmed publisher |
Wang C, Qi R, Li N, Wang Z, An H, Zhang Q, et al. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem. 2009;284:16183-90 pubmed publisher |
Szliszka E, Czuba Z, Jernas K, Kr xf3 l W. Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Mol Sci. 2008;9:56-64 pubmed publisher |
Autefage H, Albinet V, Garcia V, Berges H, Nicolau M, Therville N, et al. Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner. J Biol Chem. 2009;284:11507-16 pubmed publisher |
Xu L, Qu X, Zhang Y, Hu X, Yang X, Hou K, et al. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts. FEBS Lett. 2009;583:943-8 pubmed publisher |
Lundqvist A, Yokoyama H, Smith A, Berg M, Childs R. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells. Blood. 2009;113:6120-7 pubmed publisher |
Sun B, Moibi J, Mak A, Xiao Z, Roa W, Moore R. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments. J Urol. 2009;181:1361-71 pubmed publisher |
Fakler M, Loeder S, Vogler M, Schneider K, Jeremias I, Debatin K, et al. Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance. Blood. 2009;113:1710-22 pubmed publisher |
Mulherkar N, Prasad K, Prabhakar B. MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells. J Biol Chem. 2007;282:11715-21 pubmed |
Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir E, Yong V, et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res. 2001;61:1162-70 pubmed |
